CAS 1175526-27-8

Formula: C27H27F3N2O4

InChI: InChI=1S/C27H27F3N2O4/c1-3-32(26(35)31-16-18-7-5-4-6-8-18)17-20-15-21(27(28,29)30)10-11-22(20)23-13-19(14-25(33)34)9-12-24(23)36-2/h4-13,15H,3,14,16-17H2,1-2H3,(H,31,35)(H,33,34)

InChI key: OPXIRFWNLBDKQB-UHFFFAOYSA-N

SMILES: CCN(CC1=C(C=CC(=C1)C(F)(F)F)C2=C(C=CC(=C2)CC(=O)O)OC)C(=O)NCC3=CC=CC=C3

AM211

CAS: 1175526-27-8

AM211

Formula: C₂₇H₂₇F₃N₂O₄

Purity: ≥95%

Molecular weight: 500.51

Ref: 54-BUP03060

2-(2'-((3-Benzyl-1-ethylureido)methyl)-6-methoxy-4'-(trifluoromethyl)-[1,1'-biphenyl]-3-yl)acetic acid

CAS: 1175526-27-8

Formula: C₂₇H₂₇F₃N₂O₄

Purity: 96%

Molecular weight: 500.5095

Ref: IN-DA0097VF

AM211

CAS: 1175526-27-8

AM211 (AM211 free acid) is a potent and orally bioavailable antagonist of prostaglandin D2 (PGD2) receptor type 2 (DP2)

Formula: C₂₇H₂₇F₃N₂O₄

Purity: ≥95%

Color and Shape: White Solid

Molecular weight: 500.51

Ref: TM-T7652

AM211

CAS: 1175526-27-8

AM211 is a novel, orally active, small-molecule inhibitor of the follicle stimulating hormone (FSH) receptor. It has been shown to inhibit FSH-dependent follicle development in rats and monkeys. AM211 is an amide derivative of clomiphene and binds to the FSH receptor with high affinity. This drug also inhibits the binding of FSH to its receptor in vitro, but does not inhibit luteinizing hormone (LH) binding or LH-dependent follicle growth in vivo. Clinical studies have shown that AM211 has a half-life of 8 hours in humans, which is two times longer than that of clomiphene. The terminal half life was found to be 10 hours in monkeys. AM211 is metabolized through oxidative pathways by cytochrome P450 enzymes and exhibits pharmacokinetic properties similar to other drugs that are substrates for these enzymes.

Formula: C₂₇H₂₇F₃N₂O₄

Purity: Min. 95%

Molecular weight: 500.51 g/mol

Ref: 3D-AXB52627